Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

4d-710

Phase 2

44D Molecular Therapeutics

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Cystic Fibrosis LungRecruiting

Cystic Fibrosis LungPhase 2

Recruiting

Timeline

Expected Milestones

Q2 2031

Phase 2Recruiting

Cystic Fibrosis Lung

NCT05248230

Clinical

Trials by Indication[1]

Cystic Fibrosis Lung1 trial

An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic Fibrosis

Recruiting·44D Molecular Therapeutics·Phase 2·NCT05248230·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for 4d-710. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for 4d-710. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — 4D Molecular Therapeutics company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: 44D Molecular Therapeutics

Related News